IDEXX Laboratories (NASDAQ:IDXX) just reported results for the first quarter of 2024.
- IDEXX Laboratories reported earnings per share of $2.81. This was above the analyst estimate for EPS of $2.67.
- The company reported revenue of $964.10 million.
- This was 0.32% worse than the analyst estimate for revenue of $967.15 million.